Comparative assessment of renal function by cystatin C level in patients with hypertension and extrasystole

  • A. V. Ivankova National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • N. V. Kuzminova National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • S. E. Lozinsky National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • V. P. Ivanov National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: cystatin C, creatinine, glomerular filtration rate, essential hypertension, supraventricular extrasystole, ventricular extrasystole.

Abstract

Although the tight connection of the cardiovascular system and the kidneys is well known, using of cystatin C (Cys-C) opens new horizons in studying early renal failure stages. The study aimed to compare the functional status of the kidneys in patients with hypertension and extrasystole to the level of Cys-C. 156 patients with stage II hypertension (EH II) were examined. 124 of them had frequent symptomatic extrasystoles (74 – of supraventricular origin and 50 – ventricular), 32 patients had no arrhythmias, and were referred to the comparison group. The control group consisted of 30 healthy people with normal blood pressure (BP). All patients underwent a complete clinical examination, blood pressure measurement, daily blood pressure monitoring, daily electrocardiogram monitoring, echocardiography, and determination of renal function (creatinine, blood electrolytes, serum cystatin C) followed by calculation of glomerular filtration rate (GFR). The level of Cys-C in patients with hypertension was significantly higher (p<0.001) compared with healthy individuals. Among patients with arrhythmias, the highest level of Cys-C was noted in patients with ventricular arrhythmias. The correlation analysis showed that the level of Cys-C was higher in the presence of frequent extrasystoles (namely of ventricular origin), smoking, high blood pressure, increased systolic and pulse blood pressure, the presence of concentric left ventricular hypertrophy, dyslipidemia, increased creatinine level and decreased GFR. All three EH II patient groups had significantly lower GFR (calculated by creatinine level) (p<0.001). The lowest creatinine-based GFR was revealed in patients with ventricular extrasystole. All patients with EH II had significantly lower Cys-C based GFR than the control group (p<0.001). Mean Cys-C-based GFR values in patients with extrasystole were significantly lower than in patients without extrasystole (p<0.03). The analysis of GFR levels depending on the extrasystole origin was provided. The lowest level of GFR was recorded in patients with ventricular extrasystole. It was significantly different from the patients with supraventricular extrasystole (p=0.02). Our findings confirm the opinion of other researchers that Cys-C is an early marker of renal dysfunction in patients with hypertension, which is more sensitive than creatinine. Another finding is that ventricular extrasystole is more hemodynamically and metabolically unfavorable compared to supraventricular based on clinical and prognostic evaluation.

References

[1] Arnlov, J., Ingelsson, E., Sundstrom, J., & Lind, L. (2010). Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation, 121(2), 230-236. doi: 10.1161/CIRCULATIONAHA.109.887521
[2] Bansal, N., Zelnick, L. R., Alonso, A., Benjamin, E. J., de Boer, I. H., Deo, R., ... & Heckbert, S. R. (2017). eGFR and Albuminuria in relation to risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Clin. J. Am. Soc. Nephrol, 12(9), 1386-1398. doi: 10.2215/CJN.01860217
[3] Dangle, P. P., Ayyash, O., Kang, A., Bates, C., Fox, J., Stephany, H., & Cannon Jr, G. (2017). Cystatin C-calculated glomerular filtration rate – a marker of early renal dysfunction in patients with neuropathic bladder. Urology, (100), 213-217. doi: 10.1016/j.urology.2016.08.011
[4] Hoogendijk, M. G., Geczy, T., Yap, S., & Szili-Torok, T. (2020). Pathophysiological mechanism of premature ventricular complexes. Front Physiol, (11), 406. doi: 10.3389/fphys.2020.00406
[5] Inker, L. A., Eckfeldt, J., Levey, A. S., Leiendecker-Foster, C., Rynders, G., & Manzi, J. (2011). Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am. J. Kidney. Dis. Off J. Natl. Kidney Found, 58(4), 682-684. doi: 10.1053/j.ajkd.2011.05.019
[6] Jin, L. L., You, L., & Xie, R. Q. (2018). Value of cystatin C in predicting atrial fibrillation recurrence after radiofrequency catheter ablation. Journal of geriatric cardiology: JEH, 15(12), 725-731. doi: 10.11909/j.issn.1671-5411.2018.12.008
[7] Kayukov, I. G., Smirnov, A. V., & Emanuel, V. L. (2012). Цистатин С в современной медицине [Cystatin C in modern medicine]. Нефрология – Nephrology, 16(1), 22-39.
[8] Kharchenko, Е. P. (2015). Сердечная недостаточность при кардиоренальных синдромах [Heart failure in cardiorenal syndromes]. Терапевтический архив – Therapeutic archive, (1), 85-91.
[9] Кurjata, A. V., & Cherkasova, A. V. (2015). Артериальная гипертензия при хронической болезни почек [Arterial hypertension in chronic kidney disease]. ДМА МОЗ України – DMA of the Ministry of Health of Ukraine.
[10] Kuzminova, N. V., Ivankova, A. V., Ivanov, V. P., & Lozinsky, S. E. (2017). Diagnostic and prognostic value of cystatin C as an early marker of renal dysfunction in patiens with cardiovascular pathology. Medical business, (7-8), 17-23. doi: 0.31640/JVD.7–8.2018(3)
[11] Kuzminova, N. V., Ivankova, A. V., & Lozinsky, S. E. (2019). State of kidney function and features of metabolic status changes in patients with different forms of extrasystols. World of medicine and biology, 3(69), 83-89. doi: 10.26724/2079-8334-2019-3-69-83-89
[12] Lashkul, D. A. (2014). Структурно-функціональні зміни серця у хворих на хронічну серцеву недостатність ішемічного генезу, що асоційована з нирковою дисфункцією [Structural and functional changes of the heart in patients with chronic heart failure of ischemic origin associated with renal dysfunction]. Запорожский медицинский журнал – Zaporozhye medical journal, 2(83), 18-21.
[13] Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., Feldman, H. I., … & Coresh, J. C. K. D. (2009). CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604-612. doi: 10.7326/0003-4819-150-9-200905050-00006
[14] Li, X., Lin, H., Wang, S., Guan, L., & Wang, Y. (2016). Association of microalbuminuria with metabolic syndrome among aged population. BioMed Research International, (6), 226-233. doi: 10.1155/2016/92412788
[15] Pottel, H., Delanaye, P., Schaeffner, E., Dubourg, L., Eriksen, B. O., Melsom, T., ... & Ebert, N. (2017) Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol. Dial. Transplant, 32(3), 497-507. doi: 10.1093/ndt/gfw425
[16] Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., ... & Acute Dialysis Quality Initiative (ADQI) consensus group. (2010). Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. European heart journal, 31(6), 703-711. doi: 10.1093/eurheartj/ehp507
[17] Sirenko, U. M. (2018). Рекомендації ESC та ESH з лікування артеріальної гіпертензії [ESC and ESH recommendations for the treatment of hypertension]. Артеріальна гіпертензія – Hypertension, 5(61), 258.
[18] Sivolap, V. D., & Lashkul, D. A. (2015). Маркери фіброзу міокарда та функція нирок у хворих на хронічну серцеву недостатність ішемічного ґенезу з фібриляцією передсердь [Markers of myocardial fibrosis and renal function in patients with chronic heart failure of ischemic origin with atrial fibrillation]. Український медичний часопис – Ukrainian medical journal, 3(107), 77-79.
[19] Sherief, L. M., Youssef, D. M., Sherbiny, H. S., Abdelkhalek, E., Talaat, M., & Khalifa, N. A. (2017). Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers. Hematology, 22(5), 265-273. doi: 10.1080/10245332.2016.1259713
[20] Skibchyk, V. A., Bablyak, S. D., & Matvienko, Yu. О. (2019). Артеріальна гіпертензія і фібриляція передсердь: небезпечна “дружба”, яку не можна ігнорувати [Hypertension and atrial fibrillation: a dangerous “friendship” that cannot be ignored]. Артеріальна гіпертензія – Hypertension, 3-4(65-66), 103-109. doi: 10.22141/2224-1485.3-4.64-65.2019.177851
[21] Stevens, P. E., & Levin, A. (2013). Kidney Disease: Improving global Outcomes (KDIGO) СKD Work group. KDIGO 2012 Clinical Practice guideline for the for the Evaluation and Management of Chronic Kidney Disease. Ann. Intern. Med. 158(11), 825-830. doi: 10.7326/0003-4819-158-11-201306040-00007
[22] Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., ... & Schutte, A. E. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
[23] Voronenko, Yu. V., Shekera, O. G., & Іvanov, D. D. (2015). Актуальні питання нефрології в практиці сімейного лікаря [Current issues of nephrology in the practice of family medicine]. Сімейна медицина – Family medicine, (7), 64-87.
[24] Watanabe, H., Watanabe, T., Sasaki, S., Nagai, K., Roden, D. M., & Aizawa, Y. (2009). Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. American heart journal, 158(4), 629-636. doi: 10.1016/j.ahj.2009.06.031
[25] Zhu, Z., Zhong, C., Xu, T., Wang, A., Peng, Y., Xu, T., ... & He, J. (2018). Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atherosclerosis, (274), 146-151. doi: 10.1016/j.atherosclerosis.2018.05.015
Published
2020-12-28
How to Cite
Ivankova, A. V., Kuzminova, N. V., Lozinsky, S. E., & Ivanov, V. P. (2020). Comparative assessment of renal function by cystatin C level in patients with hypertension and extrasystole. Biomedical and Biosocial Anthropology, (41), 11-17. https://doi.org/10.31393/bba41-2020-02

Most read articles by the same author(s)